No shortage on file

CABAZITAXEL FOR INJECTION

SANDOZ CANADA INCORPORATED

Quick answers

Is there a shortage of CABAZITAXEL FOR INJECTION in Canada?

No. There is no current shortage of CABAZITAXEL FOR INJECTION 60MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file1 product

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

CABAZITAXEL FOR INJECTION

FORMATIVE PHARMA INC.

60MG · DIN 02553791

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

DIN

02487500

Strength

60MG

Dosage Form

Solution

Route

Intravenous

Active Ingredient

CABAZITAXEL

See all CABAZITAXEL products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929